ИСТИНА |
Войти в систему Регистрация |
|
ИПМех РАН |
||
From injuries to the skin to damage to the cartilage or heart, regenerative medicine has established itself in the everyday clinical practice for numerous medical indications. With their innovative approaches, the researchers active in the field of regenerative medicine are creating the basis for the advancement of medical care. This applies all the more for the broad range of ageassociated diseases that are becoming increasingly widespread as a result of demographic change, above all in industrialised countries. Still today, there are no or only unsatisfactory treatment options for many of these diseases. The key to improved health care is research funding that is aligned towards medical needs and clinical practice. To this end, the Federal Ministry of Education and Research (BMBF) has for many years accompanied the dynamic field of regenerative medicine with various and diverse measures. Since 2006, we have promoted the Translational Centre for Regenerative Medicine Leipzig (TRM) as well as other translational centres of this kind, for example in Berlin/Brandenburg, Stuttgart / NeckarAlb and Rostock. The complex and specifically patient-tailored processes pose a particular challenge on this path from research to the clinic, and so we also support innovative SMEs in their efforts to implement promising applicationoriented research and development projects. The international cooperation in the field of regenerative medicine is funded in part by joint calls with the renowned California Institute for Regenerative Medicine (CIRM). For researchers from science, clinics and industry, events such as the World Conference on Regenerative Medicine (WRM) offer an excellent platform for interexchange. But it will only be possible for the many good ideas from research to be guided along this path to the clinic, and ultimately to the patient, if this exchange about the latest trends and developments is conducted successfully and at an international level. Alongside our two hosts, the TRM and the Fraunhofer Institute for Cell Therapy and Immunology (IZI), the location of Leipzig is symbolic of this process of translation. I am very pleased that they have succeeded in establishing the WRM as a high-profile conference of international renown in Germany, and I would like to thank the organisers for their commitment and dedication. For all the participants in the WRM, I wish you a lively and fruitful exchange of ideas, rewarding networking and every success for your important research work.